Bizarre Patents
Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8178578 | Chemical compounds A compound of formula (I) is described; wherein the substituents are as defined in the text and wherein the compound is intended for use in the production of a vascular damaging effect in a warm-blooded animal. ... | 05/15/2012 |
| 8129426 | Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions containing the same derivatives and the use thereof are disclosed. The artemisinin derivatives have following formula I. It has been proved by pharmacological tests tha... | 03/06/2012 |
| 8101653 | Therapeutic compositions Compositions comprising ketone bodies and/or their metabolic precursors are provided that are suitable for administration to humans and animals and which have the properties of, inter alia, (i) increasing cardiac efficiency, particularly efficiency in use of glucose... | 01/24/2012 |
| 8101654 | Percutaneously absorptive ophthalmic preparation comprising olopatadine The present invention provides a percutaneously absorptive preparation for preventing or treating allergic eye disease, which comprises olopatadine or a salt thereof as an active ingredient. In addition, the present invention provides a method for preventing or trea... | 01/24/2012 |
| 8097648 | Methods and compositions for use in treating cancer The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer. ... | 01/17/2012 |
| 8026276 | Parenteral CCI-779 formulations containing cosolvents, an antioxidant, and a surfactant Parenteral formulations of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl) -2-methylpropionic acid (CCI-779) are provided. One parenteral formulation contains CCI-779, an alcoholic co-solvent, and an antioxidant. Another parenteral formulation contains CCI-779, ... | 09/27/2011 |
| 8013011 | Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof A method of treating a benign pigmented mole or a dermatomycosis. The method comprises locally applying to a subject in need thereof artemisinine and/or one or more structurally related compounds. Also disclosed is a plaster which comprises a topical formulation com... | 09/06/2011 |
| 7999002 | Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy The invention relates to the use of a compound of the formula (I) or a pharmaceutically acceptable addition salt thereof for the preparation of a medicament for the prophylaxis and/or treatment of muscular dystrophy. ... | 08/16/2011 |
| 7994214 | Solid dispersions comprising tacrolimus A pharmaceutical composition comprising tacrolimus (FK-506) dissolved and/or dispersed in a hydrophilic or water-miscible vehicle to form a solid dispersion or solid solution at ambient temperature have improved bioavailability. ... | 08/09/2011 |
| 7989491 | Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infections by administering artemisinin-related compounds. In certain aspects, the invention relates... | 08/02/2011 |
| 7977376 | Olopatadine formulations for topical nasal administration Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine. ... | 07/12/2011 |
| 7977375 | Antibiotic and method of production thereof The invention relates to a novel antibiotic from the macrolactin group and a microbial method for production of macrolactins and a novel isolated Bacillus subtilis, of application as the producing strain for the known Macrolactin A and the novel derivative. | 07/12/2011 |
| 7956086 | Methods for the formulation and manufacture of artesunic acid for injection A method for the manufacture of a sterile intravenous or intramuscular formulation of artesunic acid and the formulation are the subject of this invention. First the artesunic acid powder is sterilized with ethylene oxide and placed into a sterile container. The con... | 06/07/2011 |
| 7919522 | Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds Provided is a novel ivermectin derivative and compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise: (A) a pharmaceutically effective amount of a 1-N-phenylpyrazole compound; (B) a pharmac... | 04/05/2011 |
| 7915307 | Methods of improving the pharmacokinetics of doxepin Methods of improving the pharmacokinetics of doxepin in a patient. ... | 03/29/2011 |
| 7875648 | N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency The invention relates to a method of treating muscular dystrophy, such as a muscular dystrophy or myopathy resulting from mutations in genes encoding collagen VI, in a mammal. The method involves administering of a compound of the formula (I) | 01/25/2011 |
| 7868041 | Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof The present invention provides cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, methods of making cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs and compositions of cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs. The present invention also provides methods o... | 01/11/2011 |
| 7842720 | Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities This invention comprises compositions containing dihydroartemisinin- and dihydroartemisitene-dimers with activity as anticancer or anticancer metastasis agents and anti-protozal, including anti-malarial and anti-leishmanial properties. This invention also describes ... | 11/30/2010 |
| 7842719 | Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus The use of sesquiterpenes and, in particular sesquiterpene lactone endoperoxides, such as artemisinin and analogs thereof, for the treatment of hepatitis C virus infections. Artemisinin, analogs of artemsisnin and some crude Artemisia extracts were tested in ... | 11/30/2010 |
| 7807710 | Macrocycles for the treatment of cancer The invention relates to the novel macrocycles of general formula (I) and to their use in the treatment of tumor diseases. ... | 10/05/2010 |
| 7799827 | Macrocyclic compounds useful as pharmaceuticals The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of various disorders includi... | 09/21/2010 |
| 7786165 | Aminophenylpropanoic acid derivative A compound represented by the formula (1): wherein each symbol is as defined in the specification, and a salt thereof and a prodrug thereof unexpectedly have superior GPR40 receptor agonist activity, superior in the propert... | 08/31/2010 |
| 7772275 | Compositions and method for treating affective, painful or allergic disorders Therapeutic compositions of doxepin and having a preponderance of the cis doxepin isomer over the trans doxepin isomer provide therapeutic effects for affective, painful, or allergic disorders without the sedative effects commonly experienced with compositions havin... | 08/10/2010 |
| 7709524 | Use of tellurium compounds for inhibition of interleukin-converting enzyme Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleukin-1β enzyme (ICE) is beneficial is disclosed. ... | 05/04/2010 |
| 7678828 | Methods for the formulation and manufacture of artesunic acid for injection A method for the manufacture of a sterile intravenous or intramuscular formulation of artesunic acid and the formulation are the subject of this invention. First the artesunic acid powder is sterilized with ethylene oxide and placed into a sterile container. The con... | 03/16/2010 |
| 7635714 | Methods of treating dyschezia A compound of Formula (1) or a pharmaceutically acceptable salt thereof: wherein R1 represents a C1-C6 alkyl group and R2 represents a C1-C6 alkyl group, whi... | 12/22/2009 |
| 7629378 | Compositions and method for treating affective, painful or allergic disorders Therapeutic compositions of doxepin and having a preponderance of the cis doxepin isomer over the trans doxepin isomer provide therapeutic effects for affective, painful, or allergic disorders without the sedative effects commonly experienced with compositions havin... | 12/08/2009 |
| 7622497 | Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis The present invention is directed to novel derivatives of gambogic acid and analogs thereof. The present invention also relates to the discovery that novel derivatives of gambogic acid are activators of caspases and inducers of apoptosis. Therefore, the activators o... | 11/24/2009 |
| 7550503 | Physiologically active substances The present invention relates to a compound represented by the formula (I): (wherein, R3, R6, R7 and R21 are the same as or different from one another and each represents a hydrox... | 06/23/2009 |
| 7521474 | Biologically active lasonolide compounds The subject invention provides novel compositions of biologically active macrolide compounds which can advantageously be used in blocking cellular proliferation, treatment of cancer, treatment of fungal infections and control of spoilage of food, cosmetic and other ... | 04/21/2009 |
| 7470720 | Methods and compositions for use in treating cancer The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer. ... | 12/30/2008 |
| 7470719 | Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof The present invention relates to novel metastable derivatives of benzoxepines of the formula (I) in which n represents 0, 1 or 2; and the radicals R, which may be identical or different, are alkyl or alkoxy groups, or halogen atoms, which can be used in the treatmen... | 12/30/2008 |
| 7465753 | Glycoside-containing liposome A drug product which can maximize the effect of a cholestanol glycoside useful as an anticancer agent. The present invention provides a liposomal composition containing a glycoside exhibiting antitumor activity, a phospholipid, and a positive-charge-providing substa... | 12/16/2008 |
| 7459480 | Benzodioxepine derivatives This invention relates to compounds of the formula wherein B, X, Y, Z, R1 and R2 are as defined in the description, and pharmaceutically acceptable salts thereof. The invention further relates to pharm... | 12/02/2008 |
| 7456212 | Storage stable cyclic ketone peroxide compositions The present invention relates to peroxide compositions comprising one or more cyclic ketone peroxides, one or more dialkyl peroxides, and, optionally, one or more conventional phlegmatisers. These compositions are safe and storage stable. In addition, the invention ... | 11/25/2008 |
| 7452915 | Antiparasitic artemisinin derivatives (endoperoxides) This invention relates to the use of certain C-10 substituted derivatives of artemisinin of general formula (I) in the treatment and/or prophylaxis of diseases caused by infection with a parasite, certain novel C-10 substituted derivatives of artemisinin, processes ... | 11/18/2008 |
| 7439264 | Therapeutic compounds This invention to antagonists that inhibit transporters and receptors. The invention also relates to partial inhibitors of transporters and receptors that allow partial transport or partial binding of a compound to the transporter or receptor. The invention also rel... | 10/21/2008 |
| 7435754 | Laulimalide microtubule stabilizing agents A method of inhibiting the proliferation of a hyperproliferative mammalian cell having a multiple drug resistant phenotype utilizing an amount of a laulimalide compound effective to disrupt the dynamic state of microtubule polymerization and depolymerization to arre... | 10/14/2008 |
| 7417155 | Artemisinine derivatives, and uses thereof for treating malaria A new artemisinin derivatives, of following general formula (I): In which: a and b represent a single or a double bond, n1 and n2 represent 0 or 1, | 08/26/2008 |
| 7410997 | Tricyclic fused heterocycle compounds, process for preparing the same and use thereof Compounds represented by formula (1), wherein X is, for example, CH, CH2, CHR (wherein R is a lower alkyl group or a substituted lower alkyl group) or CRR′ (wherein R a... | 08/12/2008 |
